Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
CrossRef National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022 Hyeseung Lee, Seokjun Kim, Yejun Son, Soeun Kim, Hyeon Jin Kim, Hyesu Jo, Jaeyu Park, Kyeongmin Lee, Hayeon Lee, Jiseung Kang, Selin Woo, Sunyoung Kim, Sang Youl Rhee, Jiyoung Hwang, Lee Smith, Dong Keon Yon Scientific Reports.2025;[Epub] CrossRef Obesity Report: Distribution and Pattern by Age and Sex in Heart Failure Cohort over 10 Years in Korea Joongmin Kim, Geunhee Park, Haeyong Pak, Hyeongsoo Kim, Ji-Yong Jang, Hancheol Lee, Jong-Kwan Park, Seung-Jin Oh, Se-Jung Yoon Journal of Cardiovascular Development and Disease.2025
This article is independently prepared based on publicly available information and does not represent official statements issued by Sprout Health Partners LLC
Patients exploring GLP-1 coverage should also review how to get Ozempic covered by insurance for step-by-step guidance on navigating prior authorization and formulary tiers for Ozempic specifically
intestinalis ), together with reductions in specific Bacillota genera ( Akkermansia and taxa correlating negatively with inflammatory markers, and reductions in pathogenic bacteria correlating with improved metabolic profiles ( Bacteroides, Muribaculaceae, Alloprevotella, Alistipes, Blautia, Dubosiella, Enterococcus, Allobaculum, Clostridia_UCG-014, Coriobacteriaceae_UCG-002 , and notably Akkermansia , suggesting a shift toward a microbiota profile enriched in taxa linked to metabolic regulation ( Notably, oral semaglutide introduces a unique pharmacomicrobiomics paradigm compared to subcutaneous formulations
US$ 26.24
US$ 21.13
US$ 29.01
